# Xvivo Perfusion AB (publ) (XVIPF)

> Healthcare · SE · Reports in SEK

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XVIPF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | kr. 477.90M | kr. 52.44M | kr. 54.94M | kr. 12.49M | kr. 226.69M |
| 2025 | kr. 810.29M | kr. 25.05M | kr. 80.48M | kr. 237.29M | kr. 2.11B |
| 2024 | kr. 830.05M | kr. 173.78M | kr. 74.27M | N/A | kr. 2.16B |
| 2023 | kr. 608.00M | kr. 93.43M | kr. 3.33M | N/A | kr. 1.95B |
| 2022 | kr. 441.11M | kr. 19.57M | kr. 10.27M | N/A | kr. 1.43B |
| 2021 | kr. 308.31M | kr. 9.73M | kr. -26.55M | N/A | kr. 1.29B |
| 2020 | kr. 222.92M | kr. -54.20M | kr. -18.59M | N/A | kr. 1.01B |
| 2019 | kr. 275.05M | kr. 6.15M | kr. 23.82M | N/A | kr. 577.52M |
| 2018 | kr. 238.08M | kr. 16.08M | kr. 32.98M | N/A | kr. 540.48M |
| 2017 | kr. 191.83M | kr. 8.10M | kr. 21.29M | N/A | kr. 504.33M |
| 2016 | kr. 181.79M | kr. 1.97M | kr. 5.18M | kr. 0 | kr. 316.41M |
| 2015 | kr. 160.95M | kr. 6.84M | kr. 9.06M | kr. 0 | kr. 184.87M |
| 2014 | kr. 113.43M | kr. 5.01M | kr. -5.52M | kr. 0 | kr. 176.18M |
| 2013 | kr. 92.01M | kr. 10.75M | kr. 17.46M | kr. 6.66M | kr. 96.64M |
| 2012 | kr. 19.68M | kr. -1.03M | kr. -1.73M | kr. 9.09M | kr. 88.77M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.06 |
| Liabilities / Eq | 0.15 |
| Current Ratio | 3.86 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.36 |
| Gross Debt / FCF | 0.51 |

## Other views

- [Metrics](https://sponda.capital/en/XVIPF.md)
- [Charts](https://sponda.capital/en/XVIPF/charts.md)
- [Compare](https://sponda.capital/en/XVIPF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.